Renal damage during type II cryoglobulinemia;Atteinte rénale au cours des cryoglobulinémies de type II

Presse Medicale

Volumn 32, Issue 12, 2003, Pages 563-569

  Bridoux, Franck ^a   Provôt, François ^b   Ayache, Ramzi Abou ^a   Goujon, Jean Michel ^a   Touchard, Guy ^a  

^a University of Poitiers   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; PARAPROTEIN; RHEUMATOID FACTOR; RIBAVIRIN;

ANURIA; CELL INFILTRATION; CORTICOSTEROID THERAPY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; HEMATURIA; HEPATITIS C; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MICROTUBULE; MONOCYTE; MULTIPLE ORGAN FAILURE; NEPHRITIS; NEPHROTIC SYNDROME; PLASMAPHERESIS; PROTEINURIA; REVIEW; VASCULITIS;

EID: 0345073724     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974; 57: 775-88
2. Cordonnier D, Martin H, Groslambert P et al. Mixed IgG-IgM cryoglobulinemia with glomerulonephritis. Immunochemical, fluorescent and ultrastructural study of kidney and in vitro cryoprecipitate. Am J Med 1975; 59: 867-72
3. Cordonnier D, Vialtel P, Renversez JC et al. Renal diseases in 18 patients with mixed type II IgM-IgG cryoglobulinemia: monoclonal lymphoid infiltration (2 cases) and membranoproliferative glomerulonephritis (14 cases). Adv Nephrol Necker Hosp 1983; 12: 177-204
4. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-5
5. Misiani R, Bellavita R, Fenili D et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573-7
6. Tissot JD, Schifferli JA, Hochstrasser DF et al. Two-dimensional polyacrylamide gel electrophoresis analysis of cryoglobulins and identification of an IgM-associated peptide. J Immunol Methods 1994; 173: 63-75
7. Musset L, Duarte F, Gaillard O et al. Immunochemical characterization of monoclonal IgG containing mixed cryoglobulins. Clin Immunol Immunopathol 1994; 70: 166-70
8. Trejo O, Ramos-Casals M, Garcia-Carrasco et al. Cryoglobulinemia. Study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine 2001; 80: 252-62
9. Monti G, Galli M, Invernizzi F et al. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. Q J Med 1995; 88: 115-26
10. D'Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 1998; 54: 650-71
11. Tarentino A, Campise M, Banfi G et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 1995; 47: 618-23
12. Tarantino A, De Vecchi A, Montagnino G et al. Renal disease in essential mixed cryoglobulinemia. Long-term follow-up of 44 patients. Q J Med 1981; 50: 1-30
13. Meltzer M, Franklin EC, Elias K, McCluskey RJ, Cooper W. Cryoglobulinaemia. A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966; 40: 837-56
14. Cacoub P, Musset L. Cryoglobulinémies mixtes. Rev Prat 2000; 50: 276-80
15. Jacquot C, Pauti MD, Meeus F. Cryoglobulinémies, Encycl Méd Chir (Editions Scientifiques et Médicales Elsevier SAS, Paris), Néphrologie-Urologie, 18-053-D-10, Hématologie, 13-014-G-50, 2000, 9p
16. Lunel F, Musset L, Cacoub P et al. Cryoglobulinemia in liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291-300
17. Fornasieri A, D'Amico G. Type II mixed cryoglobulinemia, hepatitis C virus infection, and glomerulonephritis. Nephrol Dial Transplant 1996; 11 (Suppl 4): 25-30
18. Dussol B, Moal V, Daniel L, Pain C, Berland Y. Spontaneous remission of HCV-induced cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant 2001; 16: 156-9
19. Barton JC, Herrera GA, Galla JH, Bertoli LF, Work J, Koopman WJ. Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin. Am J Med 1987; 82: 624-9
20. Odum J, D'Costa D, Freeth M, Taylor D, Smith N, MacWhannell A. Cryoglobulinaemic vasculitis caused by intravenous immunoglobulin treatment. Nephrol Dial Transplant 2001; 16: 403-6
21. Morales E, Alegre R, Herrero JC, Morales JM, Ortuno T, Praga M. Hepatitis-C-virus-associated cryoglobulinaemic membranoproliferative glomerulonephritis in patients infected by HIV. Nephrol Dial Transplant 1997; 12: 1980-4
22. Cheng JT, Anderson HL, Markowitz GS, Appel GB, Pogue VA, D'Agati VD. Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection. J Am Soc Nephrol 1999; 10: 1566-74
23. Beaume A, Brizard A, Dreyfus B, Preud'homme J.-L. High incidence of serum monoclonal Igs detected by a sensitive immunoblotting technique in B-cell chronic lymphocytic leukemia. Blood 1994; 84: 1216-19
24. Haydey RP, Patarroyo de Rojas M, Gigli I. A newly described control mechanism of complement activation in patients with mixed cryoglobulinemia (cryoglobulins and complement). J Invest Dermatol 1980; 5: 328-32
25. Mougenot B, Ronco P. La biopsie rénale dans les dysprotéinémies et les dysglobulinémies. In: La biopsie rénale. Droz D, Lantz B, eds. Editions INSERM 1996; 237-65.
26. Herzenberg AM, Telford JJ, De Luca LG, Holden JK, Magil AB. Thrombotic microangiopathy associated with cryoglobulin membranoproliferative glomerulonephritis and hepatitis C. Am J Kidney Dis 1998; 31: 521-6
27. Zignego AL, Macchia D, Monti M. et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992; 15: 382-6
28. Gabrielli A, Manzin A, Candela M, Caniglia ML, Paolucci S, Danie Clementi M. Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinemia. Clin Exp Immunol 1994; 97: 87-93
29. D'Amico G. Is type II mixed cryoglobulinaemia an essential part of hepatitis C (HCV)-associated glomerulonephritis? Nephrol Dial Transplant 1995; 10: 1279-82
30. De Vita S, Sacco C, Sansonno D et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 1997; 90: 776-82
31. Fornasieri A, Li M, Armelloni S et al. Glomerulonephritis induced by human IgMK-IgG cryoglobulins in mice. Lab Invest 1993; 69: 531-40
32. Fornasieri A, Tazzari S, Li M. et al. Electron microscopy study of genesis and dynamics of immunodeposition in IgMk-IgG cryoglobulin-induced glomerulonephritis in mice. Am J Kidney Dis 1998; 31: 435-42
33. Fornasieri A, Armelloni S, Bernasconi P et al. High binding of immunoglobulin M. kappa rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis? Am J Kidney Dis 1996, 27: 476-83
34. Roccatello D, Morsica G, Picciotto G et al. Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C (HCV) virus infection. Clin Exp Immunol 1997; 110: 9-14
35. Roccatello D, Isidoro C, Mazzucco G et al. Role of monocytes in cryoglobulinemia-associated nephritis. Kidney Int 1993; 43: 1150-5
36. Gesualdo L, Grandaliano G, Ranieri E et al. Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. Kidney Int 1997; 51: 155-63
37. Ferri C, Marzo E, Longombardo G et al. Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 1993; 81: 1132-6
38. Misiani R, Bellavita P, Fenili D et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751-6
39. Johnson RJ, Gretch DR, Couser WG et al. Hepatitis C virus-associated glomerulonephritis. Effect of a-interferon therapy. Kidney Int 1994; 46: 1700-4
40. Dammaco F, Sansonno D, Han JH et al. Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: A long-term, randomized, controlled study. Blood 1994; 84: 3336-43
41. D'Amico G. Monoclonal cryoglobulinemia kidney. In: Monoclonal gammapathies and the kidney, Poitiers, March 22-23, 2001. Kluwer Academic Publishers, eds. Sous presse.
42. Campise M, Tarantino A. Glomerulonephritis in mixed cryoglobulinemia: what treatment? Nephrol Dial Transplant 1999; 14: 281-3
43. Casato M, Agnello V, Pucillo LP et al. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 1997; 90: 3865-73
44. Casato M, Pucillo LP, Leoni M, et al. Granulocytopenia after combined therapy with interferon and angiotensin-converting enzyme inhibitors: evidence for a synergistic hematologic toxicity. Am J Med 1995; 99: 386-91
45. Donada C, Crucitti A, Donadon V, Chemello L, Alberti A. Interferon a and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia. Blood 1998; 92: 2983-4
46. Misiani R, Bellavita P, Baio P et al. Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-a and ribavirin. Nephrol Dial Transplant 1999; 14: 1558-60
47. Pham HP, Feray C, Samuel D et al. Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver recipients. Kidney Int 1998; 54: 1311-9
48. Bojic I, Lilic D, Radojic C, Mijuskovic P. Deterioration of mixed cryoglobulinemia during treatment with interferon-alpha-2α. J Gastroenterol 1994; 29: 369-71.